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Abstract
The biological specificity of GABOB on the blood pressure, respiration and body temperature
was observed in dogs. The results show that GABOB has the similar action as GABA on the
lowering of blood pressure as shown by subcutaneous, intravenous or intrathecal injection, but
loses its action on the respiration. The specificity of GABOB action on the blood pressure is seen
in the initiation of the effect at which the transient rise in pressure can be seen, the like of which
can never be seen in the case of GABA injection. The lowering mechanism of GABOB on blood
pressure should be the central one as the intrathecal injection is most effective comparing with
those of intravenous and subcutaneous injection.
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Ever since the discovery of r-aminobutyric acid (GABA) in the brain tissue
by AWAPARA et az.t and ROBERTS et al.2 in 1950, the biological importance
of this' acid has been reported by many authors. The acid is found to be con-
tained considerably high in the brain tissue, and to be produced from glutamic
acid, which is an essential substance for the function of brain. GABA itself
also plays an important role for the function of the central nervous system8.',6.6.7.
TAKAHASHI et al. 8.10,17,18, IINo 9•1l, HAMA et az.t2,l3,19, TAKAYASU1.,
SAKAE et al.10 and TERASHI et al.16•20 have reported that GABA acts as to
lower the blood pressure and gives some effects on the respiration, when it is
introduced into vein, subcutaneous tissue or cerebellomedullary cistern.
r-Amino-j9-hydroxybutyric acid (GABOB) produced by the direct oxidation
of GABA in the brain is also known as a substance which acts as to depress the
function of the motor center. But it is not yet well established whether or not
GABOB could give any effects on the function of autonomic nervous system. In
this connection the author intended to examine the influences of GABOB on the
blood pressure, respiration and 1:xxly temperature. In this paper, the observa-
tions on these functions after the introduction of GABOB into subcutaneous
tissue, vein or cerebrospinal cavity of animals are reported.
MATERIALS AND METHODS
Eighty-five adult dogs of both sexes, weighing 5 to 15 kg were used. These
animals were devided into 4 groups, 19 animals including 3 controls in each.
The animals belonging to the first group received GABOB intravenously, 10
mg/kg of body weight in 1 per cent solution in 8 animals, 10 to 30 mg/kg of 1:xxly
* The outline of this paper was presented at the 8th Meeting of the Chugoku·Shikoku Bio-
chemical Society.
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weight in 10 per cent solution in 8 animals. Other 3 animals, controls, were intro-
duced with 3 to 5 ml of physiologic saline·solution from the same route. Of the
animals belonging to the second group, 16 animals were injected with GABOB
into subcutaneous tissue, and 3 control animals with physiologic saline solution.
The amounts of the introduced GABOB and saline were the same as those in
the cases receiving intravenous injections. The animals of the third group
received intrathecal injections. The animals of the third group received
intrathecal injections, 16 animals received GABOB and 3 animals saline.
The amounts of the injected GABOB and saline were the same as in the
former 2 groups. The animals belonging to the last group, 24 animals,
were used to confirm the minimum dose of GABOB required to cause the fall
in blood pressure. These were subdivided into 3 groups, 8 animals in each,
one group for the intravenous, the other one for subcutaneous and the last group
for intrathecal injections. GABOB used in these groups was of 1 per cent or 0.1
per cent solution. Prior to the injection the animals were anesthetized by injecting
1g of urethane and 2 mg of morphine! kg of body weight. The blood pressure in
the femoral artery was measured by inserting a cannula connected directly to the
mercury manometer. The curve of respiration was recorded on a kymographion
connected to an accordion bandage set surrounding the chest of the animals.
The rectal temperature was measured.
Crude material GABOB was donated by Ono Parmaceutical CO., Ltd.
GABOB used for this experiment was obtained from this material by recry-
stallization from the saturated solution adding pure ethanol till the solution
became muddy. This was left standing for 24 hours at 1° to 5 °Cand supernatant
was decanted. The precipitate was washed with ethanol twice and dried at room
temperature. Obtained crystals were used as a solution in distilled water and
the pH was adjusted to 7.0-7.3 by adding O.IN NaOH. Intravenous injection
was done into the femoral vein, subcutaneous injection into the femoral sub-
cutaneous tissue and intrathecal injection into the cerbellomedullary cistern after
exposing dura mater by laminectomy.
RESULTS
Influence of injected GABOB on the blood pressure
In the case of intravenous injection: The introduction of 10 mg to 30 mg
of GABOB/kg of body weight at 1 per cent or 10 per cent solutions resulted in a
transient rise in blood pressure in 15 cases of 16 animals. The blood pressure raised
immediately after the injection by 2 mmHg to 10 mmHg and then fell rapidly
reaching 'the minimum value already 12 to 36 seconds after the injection, with
the fall by 22 mmHg to 62 mmHg. Thereafter, it commenced to rise gradually
and 13 minutes to 23 minutes after the injection it returned to the original level
as shown in Tables 1, 2 and Fig. 1. The minimum dose that brings about the
2
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Table 1. The effect of GABOB on the blood pressure of dogs. The animals
received intravenous injection of 1 per cent solution once in each.
The values show the maximum and minimum points of the pressure
level after the injection. .
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Case
No.
1
2
3
4
5
6
7
8
I I Bl d Transient I Fall in blood
Bod.Yh presoosure rise in blood f Timef pressure a ter
weIg t GABOB bofore pr~,!re , a ter injection required
of dog , 'ecf InjectIOn to reach
InJ Ion - minimum
(kg) I (mg/kg) (mm/Hg) ~~:~~e[1 increase d;~=:: I decrf'.ase level
(mm/Hg) (mmiHg)j (mm/Hg) (mm/Hg)
7 I 10 148 I 148 0 124 I -24 36"
15.7 I 10 136 146 +10 86 -50 24"
5 10 142 150 + 8 98 I -44 23"
6.6 10 116 I 124 + 8 96'~ -22 12"
8.7 10 132 136 + 4 106 I -·26 32'
6.3 10 122 I 126 -I-- 4 80 -42 28"
9.2 10 118 120 + 2 84 -34 24"
7.5 10 142 I 148 + 6 96 -46 28"
Time
required
for recovery
16'
20'25"
20'
13'
12'30"
Ifj'25"
14'20"
19'10"
Table 2. The effect of GABOB on the blood pressure of dogs. The animals given
intravenous injection of 10 per cent solution once. The values show the
maximum and minimum points of the pressure level after the injection.
Blood Transient Fall in blood
Case Body pressure rise in blood pressure after Time
No. weight GABOB before pressure after injection required Timeof dog injection to reach requiredinjection
minimum for recovery
(kg) (mg/kg) (mm/Hg) elevated \ ' ea decreasod I decrease levelpressure Incr se pressure
(mm/Hg) (mm/Hg) (mm/Hg) (mm/Hg)
I
I
1 7 30 160 162 + 2 98 -62 29" 20'30"
2 15.7 10 128 132 + 4 76 -52 29" 17'
!
3 6.6 30 156 158 + 2 96 -60 27" 18'10"
4 8.7 10 134 144 +10 86 -48 11" 19'
5 6.6 10 128 136 + 8 76 -32 21" 20'20"
6 9.4 30 146 152 + 6 94 -52 26" 22'40"
7
I
5.7 30 128 136 + 8 72 -56 29" 23'15"
I
8 5.5 30 156 166 +10 108 -48 32" 19'20"
fall in blood pressure by the intravenous injection of 0.1 per cent GABOB solution
was 2001' to 500rlkg of body weight (Table 3).
No marked difference in the patterns of fall in blood pressure was recog-
nized between the cases in which GABOB was injected by 10 mg and 30 mg/kg
of body weight. The difference in the concentration of GABOB solution gave
also no significant change on the patterns of the fall in blood pressure, though
the larger the total amount of GABOB given per kilogram of body weight was,
the deeper the fall in the pressure.
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Fig. 1. The change in blood pressure in a dog (15.7 kg) seen after a single in-
jection of 10 per cent GABOB solution 10 mg/kg intravenously, total amount
15.7 m!. B. P. : Blood pressure, Resp. : Respiration, Time: 3 sec.
Table 3. Minimum dose required to cause the fall in blood pressure of the
dog in the case of intravenous injection of GABOB (0.1 per cent).
Case No.
1
2
3
4
5
7
8
Minimum dose (,)
500
300
500
200
300
200
300
500
In the case of subctaneous m]ection: The blood pressure fell slowly and
gradually comparing with those injected intravenously and it reached the lowest
level 5 minutes to 15 minutes later, showing the fall by 8 mmHg to 36 mmHg
(Tables 4, 5 and Fig. 2). Subsequently it started to rise very slowly and by 36
minutes to 53 minutes after the injection the pressure returned to the original
level. The minimum dose bringing about the fall in the blood pressure tested by
using 1 per cent GABOB solution was 5 mg to 10 mg/kg of body weight(Table 6).
The patterns of the fall hardly varied in the animals treated with the 1 per cent
and 10 per cent of GABOB solutions, whereas the depth of the fall was deeper
if the total amount was larger, similar as in the cases treated with intravenous
4
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Table 4. The effect of GABOB on the blood pressure of dogs. The animals given
subcutaneous injection of 1 per cent solution once. The values show the
maximum and minmum points of the pressure level after the injection.
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Case
No.
1
2
3
4
5
6
7
8
I Fall in bloodBod Blood Transient f
.h pressure I rise in blood pr~~ure. a ter
cled~ t GABOB .b~fo~e pr~ure. after InjectIOn
g injectIon I injectIOn d dl
I
ecrease decrease
,(kg) (mg/kg) (mm/Hg) I (mm/Hg) Ipressure
I imm/Hg) imm/Hg)
7 5 114 I (- ) 104 -10
7 10 q2 I (-) 80 -12
12 10 116 (- ) 108 - 8
5.6 10 132 (-) 120 -12
8.2 10 146 (-) 126 -20
5.6
1
10 118 (-) 106 -12
6.5 10 124 (-) 108 -16 \'
.7.7. 10 136! (-.) 124 -12
Time required
to reach
minimum
level
5'12"
6'18"
13'
15'20"
7'30"
12'
11'40"
9'20"
41'
35'30"
40'
38'10"
41'
52'40"
47 1
4220"
Table 5. The effect of GABOB on the blood presure of dogs. The animals given
subcutaneous injection of 10 per cent solution once. The values show the
maximum and minimum points of the pressure level after the injection.
Blood Transient Fall in blood ICase Body pressure rise in blood pressure after Time required
No. weight GABOB before pressure after injection to reach Time required !of dog
injection I injection decrea,ool cl minimum for recoverylevel
(kg) (mg/kg) (mm/Hg) (mm/Hg) pressure ecrease
(mm/Hg) (mm/Hg)
I1 7 30 118 (-) 92 -26 5'18" 46'
I
2 7 100 122 (-) 92 -30 12' 40'30" I
3 12 30 134 (-) 98 -36 6'20" 45'
I
I
4 5.6 30 152 (-) 134 -18 13' 41'10" iI
5 7.4 30 124 (-) 96 -28 14' 53'
I
6 8.51 30 156 (-) 134 -22 5'30" 39'40"
7 9.2
1
30 142 (-) 118 -24 7'20" 38'20"
8 6.7 30 126 (-) 96 -30 5'20" 49'
introduction.
In the cases of intrathecal injection: A transient rise in the blood prssure
by 8 mmHg to 30 mmHg occurred immediately afterwards and then fell rapidly
reaching the lowest level within 39 to 100 seconds, at which the fall was 14
mmHg to 44 mmHg. Thereafter, rising gradually it tended to revert to the
original level after 9 minutes to 29 minutes (Tables 7, 8 and Fig. 3). In the
case of intrathecal injection the minimum dose of GABOB required for the fall in
the pressure was 50r to 100rlkg of body weight as revealed byusing 0.1 per cent
5
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Fig. 2. The change in blood pressure in a dog (7 kg) seen after the single injection
of 10 per cent GABOB solution 30 mg/kg subcutaneously, total amount 2.1 ml.
B. P. : Blood pressure, Resp.: Respiration, Time: 3 sec.
Table 6. Minimum dose required to cause the fall in blood pressure of the
dog in the case of hypodermic injection of GABOB (1 per cent).
Case No.
1
2
3
4
5
6
7
8
Minimum dose (mg)
5
10
10
8
5
10
7
10
GABOB solutions (T~ble 9). Hardly any difference in the patterns of the fall
was recognized between those receiving 1 per cent and 10 per cent solutions, but
the larger the dose of GABOB given per kg of body weight the more marked
was the fall in the pressure.
Influence of GABOB injection on the respiration
Almost no effect could be recognized on the respiration, regardless of the
routes of GABOB introduction, subcutaneous, intravenous or intrathecal.
Influence of injected GABOB on the body temperature
The body temperature showed only a slight decrease by 0.2 QC to 0.3 QC
within 2 to 10 minutes after the injection, recovering to the original level by ten
6
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Table 7. The effect of GABOB on the blood pressure of dogs. The animals given
intrathecal injection of 1 per cent solution once. The values show the
maximum and minimum pressure levels after the injection.
127
Blood Transient Fall in bloodI~y! rise in blood TimeCase . pressure pr~~re. after pressure after required TimeNo. Iwelght GABOB before injection to reach required forof dog I injection mJectlOn
minimum recoveryIlkg) iImg/kgl elevated I increase decreasedldecrease level(mm/Hg), pressure pressure!(mm/Hg) (mm/Hg) (mm/Hg),(mm/Hg)
I
I
I 78 I -20 57" 24'1 7 10 98 106 + 8
I
2 15.7 5 108 118 +10 86 I -22 46" 8'30"
3 9 10 116 128 +12 92 -24 1'10" 24'10"
4 8.6 10 126 134 +12 104 :~-22 58" 23'20"
5 6.5 5 102 132 +30 86 -16 1'10" 13'20"
6 5 5 102 116 +14 78 -24 1'30" 9'30"
7 8.8 10 146 158 +12 124 -20 1'20" 27'15"
8 7 10 138 148 +10 102 -26 1'15" 19'20"
Table 8. The effecct of GABOB on the blood pressure of dogs. The animals given
intrathecal injection of 10 per cent solution once. The values show the
maximum and minimum pressure levels after the injection.
I IBlood I Transient Fall in blood
Case Body pressure rise in blood pressure after Time
No. weight GABOB before pr~ss~re. after required Timeof dog injection mJectlOn injection to reach required for\
minimum recovery
(kg) (mg/kg) (mm/Hg) :r:~~~~ I increase d;;=~:~1 decrease level
I (mm/Hg) (mm/Hg) (mm/Hg) (mm/Hg)
1 7 30 i 102 120 +18 88 -14 1'30" 25'10"
2 15.7 10 116 138 +22 96 -30 39" 17'20"
3 9 10 124 134 +20 98 -26 1'20" 26'18"
4 8.6 10 132 146 +14 102 -30 59" 29'20"
5 6.5 10 118 132 +14 96 -22 1'10" 11'20"
6 5 10 124 136 +12 84 -40 1'15" 23'30"
7 7.5 10 136 150 +14 92 -44 46" 20'10"
8 13.3 10 108 124 +12 70 -38 1'40" 24'
odd minutes to several hours. In all the three routes of injection both with the
1 per cent and the 10 per cent solution in the doses of 5 mg to 10 mg/kg of body
weight, the results were almost the same, showing no marked change in body
temperature.
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Fig. 3. The change in blood pressure in a dog (7 kg) seen after the single injection
of 1 per cent GABOB solution 10 mg/kg intrathecaly, total amount 7 m!.
B. P.: Blood pressure, Resp.: Respiration, Time: 3 sec.
Table 9. Minimum dose required to cause the fall in blood pressuse of the dog
by the injection of GABOB (0.1 per cent) into cerebellomedullary cistern.
Case No.
1
2
3
4
5
6
7
8
Minimum dose (')')
50
100
100
50
100
50
80
100
DISCUSSION
As has been briefly described, the works of T AKAHASHI, lINO and others
revealed that GABA acts as to lower the blood pressure and to disturb the re-
spiration. These findings are especially interesting in the point whether the oxi·
dation product of GABA, GABOB, still has such effects or lose the biological
specificityof GABA on the blood pressure and respiration. The results showed
that GABOB has an action to lower the blood pressure but no effect at all on
the respiration with some lowering effect on the body temperature. The fall in
8
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the blood pressure was marked and rapid when the injection was made into the
vein or cerebrospinal space comparing with the cases of subcutaneous injection,
which required a larger dose of GABOB/kg of body weight in order to attain
the similar depth of the pressure fall as in one former case and it took conside-
rably longer time to reach the minimum level, though the pressure lowering
effect of GABOB persisted for a longer period of time in the cases of intravenous
and intrathecal injections. These data show that GABOB formed by oxidation
of GABA still retains the lowering action on the blood pressure as in GABA,
though it loses its action on the respiration.
However, the falling pattern of the blood pressure is different from that
seen in the animals with GABA, in the point th~ lowering of the blood pressure
by GABOB injection is always preceded by a transient rise in pressure in the
cases of intravenous and intrathecal injections (Fig. 4). This suggests that
GABOB has a physiologic action different from GABA.
Fig. 4. The change in blood pressure in a dog (8.7 kg) seen after the single
injection of 10 per cent GABA solution 10 mg/kg intravenously. total amount
8.7 ml. B. P. : Blood pressure, Resp.: Respiration, Time: 3 sec.
As for the mechanism of the blood lowering effect of GABOB, it is sup-
posed that this substance acts primarily on the vasomotor center. The reason
lies in that the minimum dose required to induce a fall in blood pressure was
far smaller in the case of intrathecal injection than other two rout~ of injection
and when 10 mg to 100 mg of 1 per cent and 10per r.ent GABOB ~iution/kg of
9
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body weight was injected into cerebellomedullary cistern, several animals died,
and the fall in blood pressure persisted much longer than intravenous injection.
The slight lowering of body temperature seen after the GABOB injection
will probably be due to the fall in blood pressure but not due to the primary
action of GABOB.
CONCLUSION
The biological specificity of GABOB on the blood pressure, respiration and
body temperature was observed in dogs.
The results show that GABOB has the similar action as GABA on the
lowering of blood pressure as shown by subcutaneous, intravenous or intrathecal
injection, but loses its action on the respiration. The specificity of GABOB
action on the blood pressure is seen in the initiation of the effect at which
the transient rise in pressure can be seen, the like of which can never be seen
in the case of GABA injection. The lowering mechanism of GABOB on blood
pressure should be the central one as the intrathecal injection is most effective
comparing with those of intravenous and subcutaneous injection.
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